Literature DB >> 8102791

Protein-kinase-A-dependent activator in transcription factor CREB reveals new role for CREM repressors.

P Brindle1, S Linke, M Montminy.   

Abstract

Hormonally induced increases in cyclic AMP levels induce phosphorylation of the transcription factor CREB at a serine residue at position 133 by protein kinase A (ref. 1), enhancing its ability to activate transcription without affecting its intracellular location or DNA-binding activity. This effect is dependent on a 60-amino-acid region of CREB that contains Ser133 and is termed the kinase-inducible domain (KID)2, which also occurs in the CREB-related CREM-alpha and -beta proteins, although these are transcriptional repressors. Here we show that the KID domain confers a cAMP-inducible increase on the activity of the Q2 activation domain from CREB and the acidic activation domains from the yeast proteins GAL4 and GCN4. Remarkably, it retains this ability even when attached to a separate polypeptide bound to an adjacent site in the promoter. KID may therefore be the first of a new class of conditional activators that work through other promoter-bound factors to stimulate gene expression in response to hormonal stimuli.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102791     DOI: 10.1038/364821a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  42 in total

1.  DREAM-alphaCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription.

Authors:  F Ledo; A M Carrión; W A Link; B Mellström; J R Naranjo
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  The coactivator dTAF(II)110/hTAF(II)135 is sufficient to recruit a polymerase complex and activate basal transcription mediated by CREB.

Authors:  E A Felinski; P G Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

3.  Distinct cAMP response element-binding protein (CREB) domains stimulate different steps in a concerted mechanism of transcription activation.

Authors:  J Kim; J Lu; P G Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

4.  PKC alpha-mediated CREB activation is oxygen and age-dependent in rat myocardial tissue.

Authors:  Camillo Di Giulio; Monica Rapino; Maria Zingariello; Adriano Antonucci; Amelia Cataldi
Journal:  Histochem Cell Biol       Date:  2006-11-21       Impact factor: 4.304

5.  Calcium/calmodulin-dependent protein kinase II regulates cyclooxygenase-2 expression and prostaglandin E2 production by activating cAMP-response element-binding protein in rat peritoneal macrophages.

Authors:  Xueyuan Zhou; Junying Li; Wenxiu Yang
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

6.  T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.

Authors:  Nancy Dumais; Marie-Eve Paré; Simon Mercier; Salim Bounou; Susan J Marriot; Benoit Barbeau; Michel J Tremblay
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Multiple protein kinase A-regulated events are required for transcriptional induction by cAMP.

Authors:  P Brindle; T Nakajima; M Montminy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

8.  Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression.

Authors:  Kim Ravnskjaer; Henri Kester; Yi Liu; Xinmin Zhang; Dong Lee; John R Yates; Marc Montminy
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

9.  An isoform of transcription factor CREM expressed during spermatogenesis lacks the phosphorylation domain and represses cAMP-induced transcription.

Authors:  W H Walker; B M Sanborn; J F Habener
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A.

Authors:  H Wu; S K Mahata; M Mahata; N J Webster; R J Parmer; D T O'Connor
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.